Britannia Life Sciences Inc's market cap is currently C$9.94M. The company's EPS TTM is C$-0.045; its P/E ratio is ―; Britannia Life Sciences Inc is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	C$ 7.57M	C$ 6.40M	C$ 7.30M	C$ 1.42M	C$ 974.27K
Gross Profit	C$ 4.85M	C$ 4.64M	C$ 5.26M	C$ 1.17M	C$ 285.38K
Operating Income	C$ 173.00K	C$ 177.74K	C$ 379.57K	C$ 114.83K	C$ -5.20M
EBITDA	C$ -1.90M	C$ 6.95M	C$ -10.77M	C$ -1.62M	C$ -5.35M
Net Income	C$ -4.77M	C$ 5.08M	C$ -15.46M	C$ -157.16K	C$ -7.13M
Balance Sheet
Cash & Short-Term Investments	C$ 1.32M	C$ 2.60M	C$ 1.63M	C$ 828.32K	C$ 2.18M
Total Assets	C$ 22.26M	C$ 23.55M	C$ 21.09M	C$ 21.45M	C$ 3.16M
Total Debt	C$ 7.29M	C$ 8.41M	C$ 5.19M	C$ 10.55M	C$ 9.34M
Net Debt	C$ 5.96M	C$ 5.81M	C$ 3.56M	C$ 9.72M	C$ 7.16M
Total Liabilities	C$ 15.59M	C$ 12.49M	C$ 15.61M	C$ 18.79M	C$ 13.24M
Stockholders' Equity	C$ 2.44M	C$ 7.02M	C$ 1.35M	C$ -202.32K	C$ -10.08M
Cash Flow
Free Cash Flow	C$ 1.75M	C$ 874.41K	C$ 2.71M	C$ -543.49K	C$ -5.25M
Operating Cash Flow	C$ 2.09M	C$ 1.22M	C$ 2.80M	C$ -586.58K	C$ -5.18M
Investing Cash Flow	C$ -1.44M	C$ -3.32M	C$ 653.95K	C$ -4.91M	C$ -68.38K
Financing Cash Flow	C$ -1.97M	C$ 2.95M	C$ -2.58M	C$ 6.20M	C$ 3.55M

Currency in CAD

Britannia Life Sciences Inc Earnings and Revenue History

Income Statement >

Britannia Life Sciences Inc Debt to Assets

Balance Sheet >

Britannia Life Sciences Inc Cash Flow

Cash Flow >

Britannia Life Sciences Inc Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing